GL1X · GenesisL1 explorer

UniProt O60894

Maltose/maltodextrin-binding periplasmic protein,Receptor activity-modifying protein 1,Calcitonin gene-related peptide type 1 receptor (O60894)

Maltose/maltodextrin-binding periplasmic protein,Receptor activity-modifying protein 1,Calcitonin gene-related peptide type 1 receptor (UniProt O60894): 37 experimental structures on GenesisL1, 10 ligands bound, 70 pockets.…

UniProt
O60894
Protein
Maltose/maltodextrin-binding periplasmic protein,Receptor activity-modifying…
Experimental structures
37
Predicted models
0
Ligands
10
Pockets
70 · 12 records with a druggable one

Structures

37 records of O60894 in the MolNFT archive: 37 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
2YX8Crystal structure of the extracellular domain of human RAMP1x-ray diffractionA——
2YX8Crystal structure of the extracellular domain of human RAMP1x-ray diffractionA——
3N7PCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionD, E, F, R——
3N7PCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionD, E, F, R——
3N7RCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionC, D——
3N7RCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionC, D——
3N7SCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionC, D——
3N7SCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionC, D——
4RWGCrystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity CGRP…x-ray diffractionA, B, C——
4RWGCrystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity cgrp…x-ray diffractionA, B, C——
5V6YCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity…x-ray diffractionA, B, C, DGLC20 (best 0.81)
5V6YCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity…x-ray diffractionA, B, C, DNH2, GLC—
6D1UCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with…x-ray diffractionA, B, CNH2, GLC, NA—
6E3YCryo-EM structure of the active, Gs-protein complexed, human CGRP receptorelectron microscopyE—4 (best 0.76)
6E3YCryo-EM structure of the active, gs-protein complexed, human cgrp receptorelectron microscopyE——
6UMGCrystal structure of erenumab Fab bound to the extracellular domain of CGRP receptorx-ray diffractionR, r—3 (best 0.63)
6UMGCrystal structure of erenumab Fab bound to the extracellular domain of cgrp receptorx-ray diffractionR, r——
6ZHOCrystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, QLQ4 (best 0.86)
6ZHOCrystal structure of a cgrp receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, QLQ—
6ZISCrystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, 3N67 (best 0.82)
6ZISCrystal structure of a cgrp receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, 3N6—
7KNTCryoEM structure of the apo-CGRP receptor in a detergent micelleelectron microscopyE—3 (best 0.59)
7KNTCryoem structure of the apo-cgrp receptor in a detergent micelleelectron microscopyE——
7KNUCryoEM structure of the CGRP receptor with bound CGRP peptide in a detergent micelleelectron microscopyE—3 (best 0.51)
7KNUCryoem structure of the cgrp receptor with bound cgrp peptide in a detergent micelleelectron microscopyE——
7P0FCrystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, 7IR5 (best 0.86)
7P0FCrystal structure of a cgrp receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, 7IR—
7P0ICrystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor Compound…x-ray diffractionAGLC, 7IU6 (best 0.83)
7P0ICrystal structure of a cgrp receptor ectodomain heterodimer bound to macrocyclic inhibitor compound…x-ray diffractionAGLC, 7IU—
7TYFHuman Amylin1 Receptor in complex with Gs and rat amylin peptideelectron microscopyEPLM—
7TYFHuman AMYLIN1 receptor in complex with gs and rat amylin peptideelectron microscopyEPLM—
7TYWHuman Amylin1 Receptor in complex with Gs and salmon calcitonin peptideelectron microscopyEPLM—
7TYWHuman AMYLIN1 receptor in complex with gs and salmon calcitonin peptideelectron microscopyEPLM—
8AX5Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, OKU7 (best 0.84)
8AX6Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, OP94 (best 0.85)
9AUCHuman Amylin1 Receptor in Complex with Gs and human Calcitonin Gene-Related Peptideelectron microscopyEPLM4 (best 0.64)
O60894AlphaFold monomer V2.0 prediction for receptor activity-modifying protein 1 (O60894)———

Ligands

  • GLC · alpha-D-glucopyranose · in 13 records
  • PLM · Palmitic acid · in 5 records
  • 3N6 · N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl) carbonyl]pentyl}-3,5-dibromo-nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3 (2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide · in 2 records
  • 7IR · (1S,10R,23E)-12-methyl-10-[(7-methyl-1H-indazol-5-yl) methyl]-15,18,21-trioxa-5,9,12,27,29-pentazapentacyclo[23.5.2.11,4.13,7.028, 31]tetratriaconta-3(33),4,6,23,25(32),26,28(31)-heptaene-8,11,30-trione · in 2 records
  • 7IU · (1S,20E)-10-(benzofuran-3-ylmethyl)-12-methyl-15,18-dioxa-5,9,12,24,26-pentazapentacyclo[20.5.2.11,4.13, 7.025,28]hentriaconta-3(30),4,6,20,22(29),23,25(28)-heptaene-8,11,27-trione · in 2 records
  • NH2 · Amino group · in 2 records
  • QLQ · ~{N}-[(2~{R})-3-(7-methyl-2~{H}-indazol-5-yl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-piperidin-4-yl-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]amino]propan-2-yl]-2-oxidanylidene-spiro[1~{H}-pyrido[2,3-d][1,3]oxazine-4,4'-piperidine]-1'-carboxamide · in 2 records
  • NA · Sodium ion · in 1 record
  • OKU · (1~{R},10~{R},20~{E})-12-methyl-10-[(7-methyl-2~{H}-indazol-5-yl)methyl]-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3,5,7(30),20,22,24,28-heptaene-8,11,27-trione · in 1 record
  • OP9 · (1~{S},10~{R},20~{E})-12-methyl-10-[(7-methyl-2~{H}-indazol-5-yl)methyl]-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3(30),4,6,20,22,24,28-heptaene-8,11,27-trione · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.